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Different meanings of
“glomerular tip lesion”
To the Editor: The term “glomerular tip lesion” [1] has
been used with three meanings:
(1) Our original description was in nephrotic patients
with structural changes at the tubular origin in glomeruli
that were otherwise normal. The clinical course resem-
bled that of minimal change nephropathy [2].
(2) We later realized that such changes were a com-
mon finding in many disorders, such as membranous
nephropathy [3]. These tip changes were not themselves a
disease, but could only be interpreted by consideration of
the rest of the glomerulus. Others have applied the term
“glomerular tip lesion” to these changes, irrespective of
the associated condition.
(3) We also reported tip changes in glomeruli show-
ing mesangial hypercellularity in the nephrotic syndrome,
sometimes with clinical progression [3, 4]. The ones who
did badly developed segmental sclerosis, corresponding
to many descriptions of “focal segmental glomeruloscle-
rosis.” We called the early stage early classical focal seg-
mental glomerulosclerosis [4].
‘Glomerular tip lesion,’ as defined by D’Agati et al [1],
also called “the tip variant of focal segmental glomeru-
losclerosis,” clearly includes our original definition, and
excludes tip changes in conditions such as membranous
nephropathy. Their definition allows mesangial hypercel-
lularity, and some of their patients may correspond to
early classical focal segmental glomerulosclerosis. Differ-
entiation between normal mesangium and mild mesan-
gial hypercellularity is arbitrary, but at the moment there
is no other satisfactory test to identify those who may
progress.
We agree with D’Agati et al that most patients with the
“glomerular tip lesion” by their definition, have steroid
responsive nephrotic syndrome and a good prognosis.
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Reply from the Authors
We agree with Dr. Howie that glomerular tip lesion
(GTL) may occur as a primary form in patients with idio-
pathic nephrotic syndrome, or may develop secondarily
in association with heavy proteinuria in diverse glomeru-
lar diseases [1]. We limited our study to primary GTL [2].
In our series, mesangial hypercellularity did not predict
outcome, defined as remission status at last follow-up.
None of our cases of primary GTL showed more than
mild mesangial hypercellularity, which was detected in
47% of GTL biopsies. Notably, the single GTL case that
progressed to end-stage renal disease lacked mesangial
hypercellularity.
Dr. Howie has observed that those cases with “struc-
tural changes at the tubular origin in glomeruli that were
otherwise normal” had a “clinical course resembling that
of minimal change disease.” Our data have shown, for
the first time, that routinely processed renal biopsies with
GTL frequently contained glomeruli with segmental le-
sions at other sites (peripheral or indeterminate, but not
perihilar), and most of these cases similarly followed a be-
nign course. Importantly, the segmental lesions were pre-
dominantly cellular (81%), rather than sclerosing. There
was no significant difference in remission status when
cases with GTL alone (26% of cases) were compared with
cases of GTL with segmental lesions at other glomerular
locations. Remission rate for GTL was better than for
idiopathic focal segmental sclerosis controls, but not as
good as that reported for adult minimal change disease.
For these reasons, we envision GTL as occupying an in-
termediate position, morphologically and clinically, in the
minimal change disease/focal segmental glomeruloscle-
rosis spectrum [3].
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